【最全】2025年医美注射材料行业上市公司全方位对比（附业务布局汇总、业绩对比、业务规划等）

前瞻产业研究院2025-07-11

行业主要上市公司：华熙生物(688363.SH);昊海生科(688366.SH);爱美客(300896.SZ);创健医疗(873474.NQ);锦波生物(832982.BJ);巨子生物(02367.HK)等本文核心数据：相关业务销量;相关业务收入1、医美注射材料行业上市公司汇总目前，我国医美注射材料行业A股上市企业数量较少，主要A股上市企业包括：华熙生物、昊海生科、爱美、巨子生物等，多数医美注射...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2550609029?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-11 10:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2550609029","market":"sh","top_or_hot":-1,"title":"【最全】2025年医美注射材料行业上市公司全方位对比（附业务布局汇总、业绩对比、业务规划等）","media":"前瞻产业研究院","content":"<div>\n<p>行业主要上市公司：华熙生物(688363.SH);昊海生科(688366.SH);爱美客(300896.SZ);创健医疗(873474.NQ);锦波生物(832982.BJ);巨子生物(02367.HK)等本文核心数据：相关业务销量;相关业务收入1、医美注射材料行业上市公司汇总目前，我国医美注射材料行业A股上市企业数量较少，主要A股上市企业包括：华熙生物、昊海生科、爱美、巨子生物等，多数医美注射...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071110520897a1b9a9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【最全】2025年医美注射材料行业上市公司全方位对比（附业务布局汇总、业绩对比、业务规划等）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【最全】2025年医美注射材料行业上市公司全方位对比（附业务布局汇总、业绩对比、业务规划等）\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-11 10:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071110520897a1b9a9&s=b><strong>前瞻产业研究院</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>行业主要上市公司：华熙生物(688363.SH);昊海生科(688366.SH);爱美客(300896.SZ);创健医疗(873474.NQ);锦波生物(832982.BJ);巨子生物(02367.HK)等本文核心数据：相关业务销量;相关业务收入1、医美注射材料行业上市公司汇总目前，我国医美注射材料行业A股上市企业数量较少，主要A股上市企业包括：华熙生物、昊海生科、爱美、巨子生物等，多数医美注射...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071110520897a1b9a9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0229","symbol_name":"化学制品","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071110520897a1b9a9&s=b","article_id":"2550609029","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071110520897a1b9a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2550609029","pubTimestamp":1752199206,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3、医美注射材料上市企业业务布局对比当前，中国医美注射材料上市公司中，爱美客和巨子生物医美注射材料产品市场表现出色，2024年爱美客医美注射材料销售额约29.60亿元，巨子生物医美注射材料销售额约55.20亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"510620":"材料行业","688363":"华熙生物","688366":"昊海生科","BK0229":"化学制品","02367":"巨子生物","BK0239":"医药制造"},"translate_title":"[The most complete] Comprehensive comparison of listed companies in the medical aesthetic injection materials industry in 2025 (with summary of business layout, performance comparison, business planning, etc.)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"510620":1,"688363":0.9,"688366":0.9,"02367":0.9},"content_text":"行业主要上市公司：华熙生物(688363.SH);昊海生科(688366.SH);爱美客(300896.SZ);创健医疗(873474.NQ);锦波生物(832982.BJ);巨子生物(02367.HK)等本文核心数据：相关业务销量;相关业务收入1、医美注射材料行业上市公司汇总目前，我国医美注射材料行业A股上市企业数量较少，主要A股上市企业包括：华熙生物、昊海生科、爱美、巨子生物等，多数医美注射材料行业A股上市企业涉及上游原材料的供应。从我国医美注射材料产业链企业区域分布来看，山东省医美注射材料产业链企业数量较多，原材料生产企业包括华熙生物、福瑞达、阜丰集团等;器械制造企业包括威高股份等;产品研发与制造企业包括华熙生物等。2、医美注射材料上市企业基本信息对比从医美注射材料行业的上市企业布局和已有公开信息分析，成立时间最早和专利数量最多的是华熙生物，注册资本最高的是巨子生物。3、医美注射材料上市企业业务布局对比当前，中国医美注射材料上市公司中，爱美客和巨子生物医美注射材料产品市场表现出色，2024年爱美客医美注射材料销售额约29.60亿元，巨子生物医美注射材料销售额约55.20亿元。4、医美注射材料上市企业医美注射材料相关业务业绩对比目前，从上市企业医美注射材料相关产品的销量来看，华熙生物销量超千万支，昊海生科和爱美客在700万支左右，锦波生物仅124.28万支。5、医美注射材料上市企业医美注射材料业务规划对比从上市企业医美注射材料业务规划布局来看，华熙生物、昊海生科、爱美客、巨子生物、锦波生物、创健医疗六家企业在医美注射材料领域分别聚焦透明质酸与再生医学、“玻尿酸+肉毒毒素”、再生填充材料、重组胶原蛋白产品注册与标准制定、重组胶原蛋白技术突破及全链条产业化等战略方向。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2550609029","isCrawlerRequest":true}